Cargando…

A Prediction Model Based on Blood Biomarker for Mortality Risk in Patients with Acute Venous Thromboembolism

BACKGROUND: Most studies to date have focused on predicting the risk of venous thromboembolism (VTE), but prediction models about mortality risk in VTE are rarely reported. We sought to develop and validate a multivariable model to predict the all-cause mortality risk in patients with acute VTE in e...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Jianjun, Xue, Junshuai, Liu, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394732/
https://www.ncbi.nlm.nih.gov/pubmed/36003675
http://dx.doi.org/10.2147/JIR.S379360
_version_ 1784771542429728768
author Jiang, Jianjun
Xue, Junshuai
Liu, Yang
author_facet Jiang, Jianjun
Xue, Junshuai
Liu, Yang
author_sort Jiang, Jianjun
collection PubMed
description BACKGROUND: Most studies to date have focused on predicting the risk of venous thromboembolism (VTE), but prediction models about mortality risk in VTE are rarely reported. We sought to develop and validate a multivariable model to predict the all-cause mortality risk in patients with acute VTE in emergency settings. METHODS: A total of 700 patients were included from Qilu Hospital of Shandong University and were randomly assigned into training set (n=490) and validation set (n=210) in an 7:3 ratio. Multivariate logistics regression analysis was performed to identify independent variables and develop a prediction model, which was validated internally using bootstrap method. The discrimination, calibration and clinical utility were evaluated by receiver operating characteristic curve (ROC) analysis, Hosmer-Lemeshow (HL) test, Kaplan-meier (KM) analysis and decision curve analysis (DCA). RESULTS: There were 52 patients (10.6%) dying and 437 (89.4%) surviving in training set. Age (odds ratio [OR]: 4.158, 95% confidence interval [CI]: 2.426–7.127), pulmonary embolism (OR: 1.779, 95% CI: 1.124–2.814), platelet count (OR: 0.507, 95% CI: 0.310–0.830), D-dimer (OR: 1.826, 95% CI: 1.133–2.942) and platelet/lymphocyte ratio (OR: 2.166, 95% CI: 1.259–3.727) were independent risk variables associated with all-cause mortality. The model had good predictive capability with an AUC of 0.746 (95% CI: 0.668,0.825), a sensitivity of 0.769 (95% CI: 0.607,0.889), a specificity of 0.672 (95% CI: 0.634,0.707). The validation model had an AUC of 0.739 (95% CI: 0.685,0.793), a sensitivity of 0.690 (95% CI: 0.580,0.787), a specificity of 0.693 (95% CI: 0.655,0.729). The model is well calibrated and the HL test showed a good fit (χ(2)=5.291, p=0.726, Nagelkerke R(2)=0.137). KM analysis and DCA showed a good clinical utility of the nomogram. CONCLUSION: This study identified independent variables affecting all-cause mortality in patients with acute VTE, and developed a prediction model and provided a nomogram with good prediction capability and clinical utility.
format Online
Article
Text
id pubmed-9394732
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-93947322022-08-23 A Prediction Model Based on Blood Biomarker for Mortality Risk in Patients with Acute Venous Thromboembolism Jiang, Jianjun Xue, Junshuai Liu, Yang J Inflamm Res Original Research BACKGROUND: Most studies to date have focused on predicting the risk of venous thromboembolism (VTE), but prediction models about mortality risk in VTE are rarely reported. We sought to develop and validate a multivariable model to predict the all-cause mortality risk in patients with acute VTE in emergency settings. METHODS: A total of 700 patients were included from Qilu Hospital of Shandong University and were randomly assigned into training set (n=490) and validation set (n=210) in an 7:3 ratio. Multivariate logistics regression analysis was performed to identify independent variables and develop a prediction model, which was validated internally using bootstrap method. The discrimination, calibration and clinical utility were evaluated by receiver operating characteristic curve (ROC) analysis, Hosmer-Lemeshow (HL) test, Kaplan-meier (KM) analysis and decision curve analysis (DCA). RESULTS: There were 52 patients (10.6%) dying and 437 (89.4%) surviving in training set. Age (odds ratio [OR]: 4.158, 95% confidence interval [CI]: 2.426–7.127), pulmonary embolism (OR: 1.779, 95% CI: 1.124–2.814), platelet count (OR: 0.507, 95% CI: 0.310–0.830), D-dimer (OR: 1.826, 95% CI: 1.133–2.942) and platelet/lymphocyte ratio (OR: 2.166, 95% CI: 1.259–3.727) were independent risk variables associated with all-cause mortality. The model had good predictive capability with an AUC of 0.746 (95% CI: 0.668,0.825), a sensitivity of 0.769 (95% CI: 0.607,0.889), a specificity of 0.672 (95% CI: 0.634,0.707). The validation model had an AUC of 0.739 (95% CI: 0.685,0.793), a sensitivity of 0.690 (95% CI: 0.580,0.787), a specificity of 0.693 (95% CI: 0.655,0.729). The model is well calibrated and the HL test showed a good fit (χ(2)=5.291, p=0.726, Nagelkerke R(2)=0.137). KM analysis and DCA showed a good clinical utility of the nomogram. CONCLUSION: This study identified independent variables affecting all-cause mortality in patients with acute VTE, and developed a prediction model and provided a nomogram with good prediction capability and clinical utility. Dove 2022-08-18 /pmc/articles/PMC9394732/ /pubmed/36003675 http://dx.doi.org/10.2147/JIR.S379360 Text en © 2022 Jiang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Jiang, Jianjun
Xue, Junshuai
Liu, Yang
A Prediction Model Based on Blood Biomarker for Mortality Risk in Patients with Acute Venous Thromboembolism
title A Prediction Model Based on Blood Biomarker for Mortality Risk in Patients with Acute Venous Thromboembolism
title_full A Prediction Model Based on Blood Biomarker for Mortality Risk in Patients with Acute Venous Thromboembolism
title_fullStr A Prediction Model Based on Blood Biomarker for Mortality Risk in Patients with Acute Venous Thromboembolism
title_full_unstemmed A Prediction Model Based on Blood Biomarker for Mortality Risk in Patients with Acute Venous Thromboembolism
title_short A Prediction Model Based on Blood Biomarker for Mortality Risk in Patients with Acute Venous Thromboembolism
title_sort prediction model based on blood biomarker for mortality risk in patients with acute venous thromboembolism
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394732/
https://www.ncbi.nlm.nih.gov/pubmed/36003675
http://dx.doi.org/10.2147/JIR.S379360
work_keys_str_mv AT jiangjianjun apredictionmodelbasedonbloodbiomarkerformortalityriskinpatientswithacutevenousthromboembolism
AT xuejunshuai apredictionmodelbasedonbloodbiomarkerformortalityriskinpatientswithacutevenousthromboembolism
AT liuyang apredictionmodelbasedonbloodbiomarkerformortalityriskinpatientswithacutevenousthromboembolism
AT jiangjianjun predictionmodelbasedonbloodbiomarkerformortalityriskinpatientswithacutevenousthromboembolism
AT xuejunshuai predictionmodelbasedonbloodbiomarkerformortalityriskinpatientswithacutevenousthromboembolism
AT liuyang predictionmodelbasedonbloodbiomarkerformortalityriskinpatientswithacutevenousthromboembolism